TETRAPHASE PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
TETRAPHASE PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $5.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-15.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2019-03-15
- 2018-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $5.00K.
- 2017-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $2.27M.
- 2016-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $650.00K.
- 2016-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $586.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2018-12-31 | $5.00K 10-K · filed 2019-03-15 |
| 2017-12-31 | $2.27M 10-K · filed 2018-03-06 |
| 2016-12-31 | $650.00K 10-K · filed 2017-03-13 |
| 2016-09-30 | $586.00K 10-Q · filed 2016-11-03 |
| 2016-06-30 | $841.00K 10-Q · filed 2016-08-04 |
| 2016-03-31 | $1.07M 10-Q · filed 2016-05-04 |
| 2015-12-31 | $4.43M 10-K · filed 2016-02-25 |
| 2015-09-30 | $2.56M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $48.80M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $39.84M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $48.72M 10-K · filed 2015-03-06 |
| 2014-09-30 | $21.95M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $13.34M 10-Q · filed 2014-08-12 |
| 2014-03-31 | $9.41M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $13.84M 10-K · filed 2014-03-06 |
| 2013-09-30 | $11.33M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $5.87M 10-Q · filed 2013-08-12 |
| 2013-03-31 | $5.46M 10-Q · filed 2013-05-13 |